In 2020, Song et al. reported that schisandrin effectively ameliorates ERS mainly through the downregulation of CHOP, GRP78, and cleaved caspase-12 expression in the hippocampus at 14 days after STZ-induced AD [72]. This evidence concerns the gene HSPA5 and Alzheimer disease.